Convergence Investment Partners’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-107,980
| Closed | -$339K | – | 427 |
|
|
2016
Q2 | $339K | Buy |
+107,980
| New | +$339K | 0.05% | 290 |
|
|
2016
Q1 | – | Sell |
-444,724
| Closed | -$1.57M | – | 428 |
|
|
2015
Q4 | $1.57M | Buy |
444,724
+115,674
| +35% | +$409K | 0.18% | 190 |
|
|
2015
Q3 | $1.66M | Buy |
329,050
+11,814
| +4% | +$59.4K | 0.19% | 173 |
|
|
2015
Q2 | $2.04M | Buy |
317,236
+117,616
| +59% | +$756K | 0.2% | 169 |
|
|
2015
Q1 | $1.4M | Buy |
199,620
+105,630
| +112% | +$743K | 0.2% | 205 |
|
|
2014
Q4 | $725K | Sell |
93,990
-51,960
| -36% | -$401K | 0.1% | 289 |
|
|
2014
Q3 | $1.09M | Hold |
145,950
| – | – | 0.15% | 211 |
|
|
2014
Q2 | $1.41M | Buy |
145,950
+21,700
| +17% | +$210K | 0.19% | 178 |
|
|
2014
Q1 | $1.03M | Sell |
124,250
-168,954
| -58% | -$1.4M | 0.16% | 188 |
|
|
2013
Q4 | $2.48M | Buy |
293,204
+276,154
| +1,620% | +$2.33M | 0.4% | 83 |
|
|
2013
Q3 | $136K | Hold |
17,050
| – | – | 0.03% | 305 |
|
|
2013
Q2 | $132K | Buy |
+17,050
| New | +$132K | 0.03% | 306 |
|